Literature DB >> 33545932

Imaging and surgical predictive factors for postoperative hemorrhage after partial nephrectomy and clinical results of trans-arterial embolization.

Caipeng Qin1, Xin Zhi2, Fei Wang1, Qing Li1, Jian Gao2, Shijun Liu1, Tao Xu1.   

Abstract

ABSTRACT: Partial nephrectomy (PN) has been established as the standard treatment for T1 renal tumors, and postoperative hemorrhage due to vascular complications is a rare but potentially life-threatening complication reported after PN. Thus, this study evaluated the imaging and surgical factors associated with postoperative hemorrhage after PN and the clinical results of trans-arterial embolization. A retrospective review of the institutional PN database was performed from May 2012 to January 2019, revealing that we performed 810 PN procedures at our institution. In total, 12 patients were referred to the interventional radiology department for vascular complications after the procedure. Patients with and without transarterial embolization (TAE) were age- and sex-matched with 56 patients. Preoperative imaging characteristics and operative details were considered. Univariable and multivariable analyses were used to test their eventual association with the occurrence of hemorrhage. Furthermore, renal functions at diagnosis, after operation or embolization for TAE cases, and at the last follow-up were recorded. A diagnosis of hemorrhage was made at a median of 4 (range, 0-25) days after surgery. The majority of patients (50%) presented with gross hematuria. T test revealed higher renal tumor-parenchyma contact area (TPA) (P = .0407), Length-A (P = .0136), Length-P (P = .0267), operation time (P = .0214) and estimated blood loss (P = .0043) in patients with hemorrhage than in controls. Binary logistic regression analysis identified TPA (P = .048) and estimated blood loss (P = .042) as independent predictors for postoperative hemorrhage with an area under the ROC curve of 0.705 (64% sensitivity and 79% specificity). In conclusion, the occurrence of hemorrhage after PN was associated with a larger TPA and more estimated blood loss during the procedure. In patients who underwent selective TAE, renal function remained comparable with that of controls.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33545932      PMCID: PMC7837919          DOI: 10.1097/MD.0000000000023581

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  19 in total

1.  Complications of radical and partial nephrectomy in a large contemporary cohort.

Authors:  Andrew J Stephenson; A Ari Hakimi; Mark E Snyder; Paul Russo
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

2.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester
Journal:  Eur Urol       Date:  2010-12-22       Impact factor: 20.096

3.  Selective arterial embolization for pseudoaneurysms and arteriovenous fistula of renal artery branches following partial nephrectomy.

Authors:  Tarek P Ghoneim; Raymond H Thornton; Stephen B Solomon; Ari Adamy; Ricardo L Favaretto; Paul Russo
Journal:  J Urol       Date:  2011-04-15       Impact factor: 7.450

4.  Iatrogenic vascular lesions after minimally invasive partial nephrectomy: a multi-institutional study of clinical and renal functional outcomes.

Authors:  Elias S Hyams; Phillip Pierorazio; Ornab Proteek; Shyam Sukumar; Andrew A Wagner; Jodi L Mechaber; Craig Rogers; Louis Kavoussi; Mohamad Allaf
Journal:  Urology       Date:  2011-08-02       Impact factor: 2.649

5.  Renal Pseudoaneurysms and Arteriovenous Fistulas as a Complication of Nephron-Sparing Partial Nephrectomy: Technical and Functional Outcomes of Patients Treated With Selective Microcoil Embolization During a Ten-Year Period.

Authors:  F F Strobl; M D'Anastasi; R Hinzpeter; P S Franke; C G Trumm; T Waggershauser; M Staehler; D A Clevert; M Reiser; A Graser; P M Paprottka
Journal:  Rofo       Date:  2016-01-12

6.  Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience.

Authors:  Sascha Pahernik; Frederik Roos; Christian Hampel; Rolf Gillitzer; Sebastian W Melchior; Joachim W Thüroff
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

Review 7.  Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer.

Authors:  Steven MacLennan; Mari Imamura; Marie C Lapitan; Muhammad Imran Omar; Thomas B L Lam; Ana M Hilvano-Cabungcal; Pam Royle; Fiona Stewart; Graeme MacLennan; Sara J MacLennan; Philipp Dahm; Steven E Canfield; Sam McClinton; T R Leyshon Griffiths; Börje Ljungberg; James N'Dow
Journal:  Eur Urol       Date:  2012-07-20       Impact factor: 20.096

8.  Impact of continuous deterioration of kidney function 6 to 8 months after percutaneous coronary intervention for acute coronary syndrome.

Authors:  Naohiko Nemoto; Masaki Iwasaki; Mami Nakanishi; Tadashi Araki; Makoto Utsunomiya; Masaki Hori; Nobutaka Ikeda; Kunihiko Makino; Hideki Itaya; Raisuke Iijima; Hidehiko Hara; Takuro Takagi; Nobuhiko Joki; Kaoru Sugi; Masato Nakamura
Journal:  Am J Cardiol       Date:  2014-03-02       Impact factor: 2.778

Review 9.  Incidence of renal artery pseudoaneurysm following open and minimally invasive partial nephrectomy: a systematic review and comparative analysis.

Authors:  Samay Jain; Themba Nyirenda; Jennifer Yates; Ravi Munver
Journal:  J Urol       Date:  2012-12-03       Impact factor: 7.450

10.  Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.

Authors:  R Houston Thompson; Stephen A Boorjian; Christine M Lohse; Bradley C Leibovich; Eugene D Kwon; John C Cheville; Michael L Blute
Journal:  J Urol       Date:  2008-02       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.